Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 1
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Perception of disease, dyadic coping, and the quality of life of oncology patients in the active treatment phase and their life partners: an approach based on the actor-partner interdependence model.
Ştefănuţ AM, Vintilă M, Bădău LM, Grujic D, Oprean CM, Goian C, Sârbescu P. Ştefănuţ AM, et al. Among authors: oprean cm. Front Psychol. 2023 Apr 27;14:1069767. doi: 10.3389/fpsyg.2023.1069767. eCollection 2023. Front Psychol. 2023. PMID: 37179865 Free PMC article.
Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.
Vidra R, Ciuleanu TE, Nemeș A, Pascu O, Heroiu AM, Antone N, Vidrean AI, Oprean CM, Pop LA, Berindan-Neagoe I, Eniu R, Eniu A. Vidra R, et al. Among authors: oprean cm. Int J Environ Res Public Health. 2022 Apr 4;19(7):4314. doi: 10.3390/ijerph19074314. Int J Environ Res Public Health. 2022. PMID: 35409996 Free PMC article.
Attitudes towards COVID‑19 vaccination in patients with cancer: A cross‑sectional study of 12 oncology centers.
Lazar R, Oprean CM, Badau LM, Miron G, Draganescu L, Torok-Vistai T, Coroian I, Sabau D, Iliescu A, Tamas LA, Hosu S, Curca R, Gatej A, Hora A, Ungureanu A, Parvu D, Valean D, Usatiuc LO, Vidra R. Lazar R, et al. Among authors: oprean cm. Mol Clin Oncol. 2022 Nov 1;17(6):162. doi: 10.3892/mco.2022.2595. eCollection 2022 Dec. Mol Clin Oncol. 2022. PMID: 36479255 Free PMC article.
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients.
Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Gligorov J, et al. Eur J Cancer. 2017 Sep;82:237-246. doi: 10.1016/j.ejca.2017.05.010. Epub 2017 Jun 16. Eur J Cancer. 2017. PMID: 28625777 Clinical Trial.